Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Portman currently holds 2,936,854 shares of PACIFICHEALTH LABORATORIES INC (PHLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Portman has been a net buyer of PHLI stock. They have purchased $320.4K and sold $47.0K worth of shares.
Robert Portman's most recent insider trade was on May 11, 2011, when they purchased 400,000 shares at $0.25 per share.
Robert Portman serves as Executive at PACIFICHEALTH LABORATORIES INC (PHLI). They have executed 26 insider transactions totaling $367.4K over their tenure at the company.
Robert Portman holds the position of Executive at PACIFICHEALTH LABORATORIES INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robert Portman has shown a buying trading pattern, with $320.4K in total purchases and $47.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert Portman was on Jan 3, 2006, when they sold $142.6K worth of PHLI shares. This transaction involved 460,000 shares at $0.31 per share.
Robert Portman currently owns 2,936,854 shares of PACIFICHEALTH LABORATORIES INC (PHLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Portman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Portman has 26 Form 4 filings on record as an insider at PACIFICHEALTH LABORATORIES INC.
Set alerts for Robert Portman and 40,000+ other insiders.